Rituximab

Rituximab, is a chimeric mouse/human monoclonal antibody (Rituxan) specific for the B-cell surface molecule CD20 that has been approved for the treatment of CD20+ low-grade or follicular non-Hodgkin's lymphoma. Since B lymphocytes play a crucial role in the pathogenesis of LE, anti-CD20 was considered to be valuable for the treatment of SLE. Therefore, a single-center, open-label, dose-escalation phase I/II trial was performed in 18 patients with active, but not organ-threatening, disease(Anolik et al. 2000). The treatment was well tolerated, and symptoms such as rash, arthritis, and fatigue markedly improved. Moreover, even low-dose rituximab therapy resulted in B-lymphocyte depletion. Further studies will reveal whether this promising approach ultimately will be a useful therapy for LE (Anolik et al. 2000).

Was this article helpful?

0 0
Natural Arthritis Pain Remedies

Natural Arthritis Pain Remedies

It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.

Get My Free Ebook


Post a comment